Группа авторов

Metabolic Syndrome Consequent to Endocrine Disorders


Скачать книгу

AF, de Graaf J: Association of fasting glucose and non-fasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL. Curr Opin Lipidol 2008;19:355–361.

      35Rizzo M, Trepp R, Bernies K, Christ ER: Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclass in patients with growth hormone deficiency before and after short-term replacement therapy. Eur J Endocrinol 2007;156:361–367.

      43Bramnert M, Segerlantz M, Laurila E, Daugaard JR, Manhem P, Groop L: Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle. J Clin Endocrinol Metab 2003;88:1455–1463.

      44Gillberg P, Bramnert M, Thorén M, Werner S, Johansson G: Commencing growth hormone replacement in adults with a fixed low dose. Effects on serum lipoproteins, glucose metabolism, body composition and cardiovascular function. Growth Horm IGF Res 2001;11:273–281.

      45Arafat AM, Möhlig M, Weickert MO, Schöfl C, Spranger J, Pfeifer AF: Improved insulin sensitivity, preserved beta cell function and improved whole-body glucose metabolism after low-dose growth hormone replacement therapy in adults with severe growth hormone deficiency: a pilot study. Diabetologia 2010;53;1304–1313.

      46Giavoli C, Cappiello V, Corbetta S, et al: Different effects of short term and long-term recombinant hGH administration on ghrelin and adiponectin levels in GH-deficient adults. Clin Endocrinol 2004;61:81–87.